“Clinical Predictors of Response to Treatment With Tofacitinib (Janus Kinase Inhibitor) in Patients With Ankylosing Spondylitis”. 2025. Indus Journal of Bioscience Research 3 (4): 175-81. https://doi.org/10.70749/ijbr.v3i4.1020.